María Obdulia
Rabal Gracia
Investigadora hasta 2019
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat de Barcelona (9)
2024
-
Epigenetic-based differentiation therapy for Acute Myeloid Leukemia
Nature Communications, Vol. 15, Núm. 1
2018
-
Development and Validation of Molecular Overlays Derived from Three-Dimensional Hydrophobic Similarity with PharmScreen
Journal of Chemical Information and Modeling, Vol. 58, Núm. 8, pp. 1596-1609
2017
-
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice
Neuropsychopharmacology, Vol. 42, Núm. 2, pp. 524-539
-
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies
Nature Communications, Vol. 8
-
Information retrieval and text mining technologies for chemistry
Chemical Reviews, Vol. 117, Núm. 12, pp. 7673-7761
2016
-
Two affinity sites of the cannabinoid subtype 2 receptor identified by a novel homogeneous binding assay
Journal of Pharmacology and Experimental Therapeutics, Vol. 358, Núm. 3, pp. 580-587
2015
2007
-
Solid-phase synthesis of a combinatorial library of dihydroceramide analogues and its activity in human alveolar epithelial cells
Bioorganic and Medicinal Chemistry, Vol. 15, Núm. 1, pp. 50-62
2006
-
Design, synthesis and activity as acid ceramidase inhibitors of 2-oxooctanoyl and N-oleoylethanolamine analogues
Chemistry and Physics of Lipids, Vol. 144, Núm. 1, pp. 69-84